昆蟲細胞培養市場規模、佔有率和成長分析：按產品、應用、最終用戶、通路和地區分類－2026-2033年產業預測

2024 年全球昆蟲細胞培養市場價值為 8.5 億美元，預計到 2025 年將成長至 9.3 億美元，到 2033 年將成長至 19.5 億美元，在預測期（2026-2033 年）內複合年成長率為 9.62%。

由於昆蟲細胞培養在重組蛋白、疫苗和基因治療載體的生產中發揮重要作用，全球昆蟲細胞培養市場正經歷顯著成長。諸如Sf9和High-Five等昆蟲細胞能夠實現高密度培養，忠實地模擬哺乳動物系統，同時保持成本效益。對可擴展生物製造日益成長的需求，特別是為應對疫苗生產需求的不斷成長，正在推動市場擴張。改良的桿狀病毒表現載體已使昆蟲細胞培養成為傳統細胞株的實用替代方案。此外，支持環境友善生物製程的監管激勵措施鼓勵製造商採用昆蟲系統，從而減少資源消耗和廢棄物。隨著企業將基於昆蟲的平台整合到其服務中，對自動化和高通量篩檢的投資正在降低中小型生物技術公司的准入門門檻，並將目標市場擴展到治療、診斷和農業生物製品等領域。

全球昆蟲細胞培養市場促進因素

全球昆蟲細胞培養市場的發展動力源自於企業對昆蟲細胞平台的日益青睞。與傳統的哺乳動物細胞系統相比，昆蟲細胞平台具有許多優勢，例如加速蛋白質表現和降低生產成本。這種高效性使得企業能夠更靈活地回應市場需求，從而加速新型療法、疫苗和基因療法的創新。此外，昆蟲細胞培養的擴充性與不斷成長的生物製藥產品線相輔相成，促使主要生產商在其生產過程中採用這項技術，進而推動市場擴張。另外，昆蟲細胞污染風險低，且生產週期短，是快速擴大生產規模的理想選擇。

全球昆蟲細胞培養市場的限制因素

由於昆蟲細胞衍生生物製藥法規結構的不斷演變，全球昆蟲細胞培養市場面臨許多限制因素。監管機構通常要求進行廣泛的安全性和驗證性測試，以消除人們對病毒污染、特定聚醣模式以及昆蟲來源蛋白免疫抗原性的擔憂，這使得製造商在核准過程中面臨許多不確定性。這種不確定性會導致研發週期延長和合規成本增加，迫使企業在獲得更明確的指導方針之前，對昆蟲衍生技術猶豫不決或縮減投資。此外，缺乏標準化的測試方案迫使開發人員自行建立檢驗流程，從而導致資源消耗和新產品上市延遲。

全球昆蟲細胞培養市場趨勢

全球昆蟲細胞培養市場正呈現出向永續蛋白來源發展的顯著趨勢，這主要得益於消費者對環保替代品日益成長的需求。生物製藥公司擴大採用昆蟲細胞平台作為傳統哺乳動物系統的可再生替代方案，他們認知到昆蟲細胞平台具有諸多優勢，例如碳排放減少、用水量降低以及生質能生產的擴充性。這一趨勢正在加速與昆蟲衍生技術供應商的策略合作，並促進研發投入。因此，注重環保的產品平臺正在獲得競爭優勢，吸引具有社會責任感的投資者，並確保在瞬息萬變的市場環境中實現長期發展。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 宏觀經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球昆蟲細胞培養市場規模：依產品分類

• 昆蟲細胞株（Sf9）
• Hi5
• Sf21
• 桿狀病毒表現載體
• 細胞培養基和添加劑

全球昆蟲細胞培養市場規模：依應用領域分類

• 重組蛋白生產
• 桿狀病毒類病毒顆粒（VLP）疫苗
• 藥物發現

全球昆蟲細胞培養市場規模：依最終用戶分類

• 製藥和生物技術公司
• 研究機構
• CRO

全球昆蟲細胞培養市場規模：依通路分類

• 直接B2B
• 銷售代理
• 線上

全球昆蟲細胞培養市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Thermo Fisher Scientific（ExpiSf）
• Merck KGaA（Sigma-Aldrich）
• Oxford Expression Technologies
• Expression Systems LLC
• Kerafast Inc.
• Creative Biolabs
• Danaher（Cytiva）
• Charles River Laboratories
• Lonza Group
• Geneart（Thermo Fisher）
• ATUM Inc.
• Syngene International
• LakePharma
• Allele Biotech
• Viral Vectors Ltd.
• OxGene（Oxford Biomedica）
• AccelBio
• Applied Biological Materials
• Integrated BioTherapeutics
• BacVector（Novagen）

結論與建議

Global Insect Cell Culture Market size was valued at USD 0.85 Billion in 2024 and is poised to grow from USD 0.93 Billion in 2025 to USD 1.95 Billion by 2033, growing at a CAGR of 9.62% during the forecast period (2026-2033).

The global insect cell culture market is experiencing significant growth due to its role in generating recombinant proteins, vaccines, and gene therapy vectors. Insect cells like Sf9 and High-Five offer high-density cultures that closely mimic mammalian systems while maintaining cost-effectiveness. The increasing need for scalable biomanufacturing, particularly in response to heightened vaccine production demands, has fueled market expansion. Enhanced baculovirus expression vectors have established insect cell culture as a viable alternative to traditional cell lines. Additionally, regulatory incentives favoring green bioprocessing have prompted manufacturers to adopt insect systems, reducing resource consumption and waste. As companies integrate insect-based platforms into their services, automation and high-throughput screening investments lower barriers for smaller biotech firms, broadening the addressable market across therapeutics, diagnostics, and agricultural biologics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Insect Cell Culture market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Insect Cell Culture Market Segments Analysis

Global insect cell culture market is segmented by product, application, end-user, distribution and region. Based on product, the market is segmented into Insect Cell Lines (Sf9, Hi5, Sf21), Baculovirus Expression Vectors and Cell Culture Media & Supplements. Based on application, the market is segmented into Recombinant Protein Production, Baculovirus-Like Particle (VLP) Vaccines and Drug Discovery. Based on end-user, the market is segmented into Pharma & Biotech Companies, Research Institutes and CROs. Based on distribution, the market is segmented into Direct B2B, Distributors and Online. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Insect Cell Culture Market

The Global Insect Cell Culture market is being driven by a growing preference among companies for insect cell platforms, which offer advantages such as accelerated protein expression and reduced manufacturing costs relative to traditional mammalian systems. This efficiency allows for a more agile response to market demands and fosters the innovation of new therapeutics, vaccines, and gene therapies. Furthermore, the scalable nature of insect cell cultures complements the increasing pipeline of biologics, leading manufacturers to adopt this technology in their production processes, thereby fueling market expansion. Additionally, insect cells present a lower risk of contamination and facilitate shorter batch cycles, making them an ideal option for rapid scale-up in production.

Restraints in the Global Insect Cell Culture Market

The Global Insect Cell Culture market faces significant restraints due to the evolving regulatory frameworks surrounding biologics derived from insect cells. Manufacturers encounter ambiguity regarding approval processes, as regulatory agencies often necessitate extensive safety and validation studies to mitigate concerns related to viral contaminants, specific glycosylation patterns, and the immunogenicity of insect-derived proteins. This uncertainty can extend development timelines and inflate compliance costs, causing companies to hesitate or scale back investments in insect-based technologies until more definitive guidelines are presented. Furthermore, the absence of standardized testing protocols compels developers to create custom validation pathways, thereby depleting resources and delaying the launch of new products.

Market Trends of the Global Insect Cell Culture Market

The Global Insect Cell Culture market is witnessing a significant trend towards sustainable protein sources in response to rising consumer demand for environmentally friendly alternatives. Biopharmaceutical companies are increasingly turning to insect cell platforms, recognizing their potential as renewable substitutes for traditional mammalian systems due to their lower carbon footprint, reduced water consumption, and scalability in biomass production. This trend has spurred strategic partnerships with insect-based technology providers, driving investments in research and development. As a result, eco-conscious product pipelines are gaining competitive advantages, appealing to socially responsible investors and ensuring long-term viability in the evolving market landscape.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Insect Cell Culture Market Size by Product & CAGR (2026-2033)

• Market Overview
• Insect Cell Lines (Sf9)
• Hi5
• Sf21
• Baculovirus Expression Vectors
• Cell Culture Media & Supplements

Global Insect Cell Culture Market Size by Application & CAGR (2026-2033)

• Market Overview
• Recombinant Protein Production
• Baculovirus-Like Particle (VLP) Vaccines
• Drug Discovery

Global Insect Cell Culture Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Pharma & Biotech Companies
• Research Institutes
• CROs

Global Insect Cell Culture Market Size by Distribution & CAGR (2026-2033)

• Market Overview
• Direct B2B
• Distributors
• Online

Global Insect Cell Culture Market Size & CAGR (2026-2033)

• North America (Product, Application, End-User, Distribution)
  • US
  • Canada
• Europe (Product, Application, End-User, Distribution)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-User, Distribution)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-User, Distribution)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-User, Distribution)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Thermo Fisher Scientific (ExpiSf)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Sigma-Aldrich)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Expression Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Expression Systems LLC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kerafast Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (Cytiva)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Charles River Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geneart (Thermo Fisher)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ATUM Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Syngene International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LakePharma
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allele Biotech
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Viral Vectors Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OxGene (Oxford Biomedica)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AccelBio
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biological Materials
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated BioTherapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BacVector (Novagen)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations